Chugai Pharmaceutical (OTCMKTS:CHGCY - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.18 earnings per share for the quarter, Zacks reports. Chugai Pharmaceutical had a return on equity of 22.16% and a net margin of 33.07%.
Chugai Pharmaceutical Stock Down 3.4 %
Shares of OTCMKTS:CHGCY traded down $0.75 on Monday, reaching $21.61. 152,872 shares of the company's stock were exchanged, compared to its average volume of 216,050. The business's 50-day moving average is $21.68 and its two-hundred day moving average is $22.49. Chugai Pharmaceutical has a fifty-two week low of $14.52 and a fifty-two week high of $26.00. The firm has a market capitalization of $71.12 billion, a price-to-earnings ratio of 28.07 and a beta of 0.81.
Chugai Pharmaceutical Company Profile
(
Get Free Report)
Chugai Pharmaceutical Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.
Read More
Before you consider Chugai Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chugai Pharmaceutical wasn't on the list.
While Chugai Pharmaceutical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
